Related Experiment Videos

IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer

Xiaoyan Cui1, Seok-Chul Yang, Sherven Sharma

  • 1Lung Cancer Research Program of the Jonsson Comprehensive Cancer Center, and Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Biochemical and Biophysical Research Communications
|April 1, 2006
PubMed

Insights

Interleukin-4 (IL-4) reduces prostaglandin E2 (PGE2) production in non-small cell lung cancer (NSCLC) by inhibiting cyclooxygenase-2 (COX-2) gene transcription. This suggests IL-4

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Interleukin-4 (IL-4) is a pleiotropic cytokine with potential roles in the non-small cell lung cancer (NSCLC) microenvironment.
  • Prostaglandin E2 (PGE2) is a lipid mediator implicated in cancer progression and inflammation.

Purpose of the Study:

  • To investigate the effect of IL-4 on PGE2 production in NSCLC cells.
  • To elucidate the molecular mechanisms underlying IL-4's regulation of PGE2 synthesis in NSCLC.

Main Methods:

  • Assessed COX-2 expression and PGE2 production in NSCLC cell lines (A427, H2122, A549, RH2) treated with IL-4.
  • Quantified COX-2 mRNA levels and performed promoter analysis to evaluate transcriptional regulation.
  • Investigated the role of extracellular signal-regulated kinase (ERK) phosphorylation and other arachidonic acid pathway enzymes (mPGES-1, 15-PGDH).

Main Results:

  • IL-4 inhibited both constitutive and IL-1beta-induced COX-2 expression and PGE2 production in NSCLC cells.
  • IL-4 decreased COX-2 mRNA levels, indicating inhibition at the transcriptional level.
  • IL-4 suppressed IL-1beta-stimulated ERK phosphorylation, suggesting a potential mediating pathway for COX-2 inhibition.

Conclusions:

  • IL-4 significantly inhibits COX-2 mRNA transcription in NSCLC cells.
  • The observed reduction in PGE2 production by IL-4 is primarily dependent on the suppression of COX-2.
  • IL-4's inhibitory effect on COX-2 transcription, potentially mediated by ERK signaling, offers insights into NSCLC microenvironment modulation.

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...